AAPL314.86-2.45 (-0.77%) ▼|ABBV244.78-3.22 (-1.30%) ▼|ABT88.97-3.15 (-3.41%) ▼|ACN134.53-3.99 (-2.88%) ▼|ADBE220.78-9.83 (-4.26%) ▼|AMAT595.70+20.31 (+3.53%) ▲|AMD548.13+13.74 (+2.57%) ▲|AMGN355.25-5.20 (-1.44%) ▼|AMT168.85-0.65 (-0.38%) ▼|AMZN247.49+0.18 (+0.07%) ▲|AVGO389.11+5.06 (+1.32%) ▲|AXP355.15+0.72 (+0.20%) ▲|BA217.20+1.69 (+0.78%) ▲|BAC60.64+1.14 (+1.91%) ▲|BKNG174.85-0.95 (-0.54%) ▼|BLK1,025.91-5.65 (-0.55%) ▼|BMY56.98-2.36 (-3.98%) ▼|BNY154.48+3.21 (+2.12%) ▲|BRK-B491.18-5.67 (-1.14%) ▼|C133.28-7.43 (-5.28%) ▼|CAT933.82+2.35 (+0.25%) ▲|CL91.03-2.18 (-2.34%) ▼|CMCSA23.19-0.78 (-3.25%) ▼|COF205.33+2.31 (+1.14%) ▲|COP111.87-0.98 (-0.87%) ▼|COST921.75-4.68 (-0.51%) ▼|CRM167.61-3.61 (-2.11%) ▼|CSCO117.09-2.16 (-1.81%) ▼|CVS106.18+0.28 (+0.26%) ▲|CVX181.77-0.43 (-0.24%) ▼|DE584.55-1.09 (-0.19%) ▼|DHR199.06-1.11 (-0.55%) ▼|DIS95.88-0.13 (-0.13%) ▼|DUK126.38-0.48 (-0.38%) ▼|EMR136.12+0.74 (+0.55%) ▲|FDX313.65-0.09 (-0.03%) ▼|GD369.47-3.31 (-0.89%) ▼|GE353.47+0.05 (+0.01%) ▲|GEV1,066.92+24.32 (+2.33%) ▲|GILD130.04-1.36 (-1.04%) ▼|GM76.87+0.15 (+0.20%) ▲|GOOG357.33+6.66 (+1.90%) ▲|GOOGL359.51+7.00 (+1.99%) ▲|GS1,141.74+95.83 (+9.16%) ▲|HD337.87+0.76 (+0.23%) ▲|HON222.68+0.43 (+0.19%) ▲|IBM217.05-73.18 (-25.21%) ▼|INTC107.76+4.64 (+4.50%) ▲|INTU282.43-7.33 (-2.53%) ▼|ISRG379.50-27.62 (-6.78%) ▼|JNJ253.84-3.93 (-1.52%) ▼|JPM343.00+8.47 (+2.53%) ▲|KO83.08-1.17 (-1.39%) ▼|LIN522.54-1.52 (-0.29%) ▼|LLY1,153.56-28.31 (-2.40%) ▼|LMT515.07-5.61 (-1.08%) ▼|LOW207.67-0.03 (-0.01%) ▼|LRCX346.10+16.18 (+4.90%) ▲|MA538.18+0.48 (+0.09%) ▲|MCD268.88-3.73 (-1.37%) ▼|MDLZ58.80-1.06 (-1.77%) ▼|MDT79.31-4.27 (-5.10%) ▼|META661.04+4.31 (+0.66%) ▲|MMM156.52-1.18 (-0.75%) ▼|MO70.18-1.70 (-2.36%) ▼|MRK120.80-3.23 (-2.60%) ▼|MS228.09+7.00 (+3.17%) ▲|MSFT384.93-6.06 (-1.55%) ▼|MU983.12+46.12 (+4.92%) ▲|NEE89.54+1.16 (+1.31%) ▲|NFLX73.53-0.30 (-0.41%) ▼|NKE42.87-0.89 (-2.03%) ▼|NOW104.85-6.41 (-5.76%) ▼|NVDA211.80+8.27 (+4.06%) ▲|ORCL127.97-3.57 (-2.71%) ▼|PEP135.45-3.04 (-2.20%) ▼|PFE24.26-0.23 (-0.92%) ▼|PG146.10-2.27 (-1.53%) ▼|PLTR133.72+3.68 (+2.83%) ▲|PM176.10-4.09 (-2.27%) ▼|QCOM178.10-5.88 (-3.20%) ▼|RTX193.39-3.00 (-1.53%) ▼|SBUX106.17-1.17 (-1.09%) ▼|SCHW101.10-1.28 (-1.25%) ▼|SO95.96-0.51 (-0.53%) ▼|SPG221.28+1.79 (+0.82%) ▲|T21.30-0.26 (-1.18%) ▼|TMO534.62+6.11 (+1.16%) ▲|TMUS187.13-1.28 (-0.68%) ▼|TSLA396.18+1.42 (+0.36%) ▲|TXN305.55+6.98 (+2.34%) ▲|UBER72.08-2.18 (-2.94%) ▼|UNH425.19-3.90 (-0.91%) ▼|UNP288.30-0.83 (-0.29%) ▼|UPS113.67+0.78 (+0.69%) ▲|USB62.14-0.20 (-0.32%) ▼|V356.02-1.73 (-0.48%) ▼|VZ42.47-0.21 (-0.49%) ▼|WFC85.36-2.31 (-2.63%) ▼|WMT113.70-1.08 (-0.94%) ▼|XOM145.09+0.58 (+0.40%) ▲|AAPL314.86-2.45 (-0.77%) ▼|ABBV244.78-3.22 (-1.30%) ▼|ABT88.97-3.15 (-3.41%) ▼|ACN134.53-3.99 (-2.88%) ▼|ADBE220.78-9.83 (-4.26%) ▼|AMAT595.70+20.31 (+3.53%) ▲|AMD548.13+13.74 (+2.57%) ▲|AMGN355.25-5.20 (-1.44%) ▼|AMT168.85-0.65 (-0.38%) ▼|AMZN247.49+0.18 (+0.07%) ▲|AVGO389.11+5.06 (+1.32%) ▲|AXP355.15+0.72 (+0.20%) ▲|BA217.20+1.69 (+0.78%) ▲|BAC60.64+1.14 (+1.91%) ▲|BKNG174.85-0.95 (-0.54%) ▼|BLK1,025.91-5.65 (-0.55%) ▼|BMY56.98-2.36 (-3.98%) ▼|BNY154.48+3.21 (+2.12%) ▲|BRK-B491.18-5.67 (-1.14%) ▼|C133.28-7.43 (-5.28%) ▼|CAT933.82+2.35 (+0.25%) ▲|CL91.03-2.18 (-2.34%) ▼|CMCSA23.19-0.78 (-3.25%) ▼|COF205.33+2.31 (+1.14%) ▲|COP111.87-0.98 (-0.87%) ▼|COST921.75-4.68 (-0.51%) ▼|CRM167.61-3.61 (-2.11%) ▼|CSCO117.09-2.16 (-1.81%) ▼|CVS106.18+0.28 (+0.26%) ▲|CVX181.77-0.43 (-0.24%) ▼|DE584.55-1.09 (-0.19%) ▼|DHR199.06-1.11 (-0.55%) ▼|DIS95.88-0.13 (-0.13%) ▼|DUK126.38-0.48 (-0.38%) ▼|EMR136.12+0.74 (+0.55%) ▲|FDX313.65-0.09 (-0.03%) ▼|GD369.47-3.31 (-0.89%) ▼|GE353.47+0.05 (+0.01%) ▲|GEV1,066.92+24.32 (+2.33%) ▲|GILD130.04-1.36 (-1.04%) ▼|GM76.87+0.15 (+0.20%) ▲|GOOG357.33+6.66 (+1.90%) ▲|GOOGL359.51+7.00 (+1.99%) ▲|GS1,141.74+95.83 (+9.16%) ▲|HD337.87+0.76 (+0.23%) ▲|HON222.68+0.43 (+0.19%) ▲|IBM217.05-73.18 (-25.21%) ▼|INTC107.76+4.64 (+4.50%) ▲|INTU282.43-7.33 (-2.53%) ▼|ISRG379.50-27.62 (-6.78%) ▼|JNJ253.84-3.93 (-1.52%) ▼|JPM343.00+8.47 (+2.53%) ▲|KO83.08-1.17 (-1.39%) ▼|LIN522.54-1.52 (-0.29%) ▼|LLY1,153.56-28.31 (-2.40%) ▼|LMT515.07-5.61 (-1.08%) ▼|LOW207.67-0.03 (-0.01%) ▼|LRCX346.10+16.18 (+4.90%) ▲|MA538.18+0.48 (+0.09%) ▲|MCD268.88-3.73 (-1.37%) ▼|MDLZ58.80-1.06 (-1.77%) ▼|MDT79.31-4.27 (-5.10%) ▼|META661.04+4.31 (+0.66%) ▲|MMM156.52-1.18 (-0.75%) ▼|MO70.18-1.70 (-2.36%) ▼|MRK120.80-3.23 (-2.60%) ▼|MS228.09+7.00 (+3.17%) ▲|MSFT384.93-6.06 (-1.55%) ▼|MU983.12+46.12 (+4.92%) ▲|NEE89.54+1.16 (+1.31%) ▲|NFLX73.53-0.30 (-0.41%) ▼|NKE42.87-0.89 (-2.03%) ▼|NOW104.85-6.41 (-5.76%) ▼|NVDA211.80+8.27 (+4.06%) ▲|ORCL127.97-3.57 (-2.71%) ▼|PEP135.45-3.04 (-2.20%) ▼|PFE24.26-0.23 (-0.92%) ▼|PG146.10-2.27 (-1.53%) ▼|PLTR133.72+3.68 (+2.83%) ▲|PM176.10-4.09 (-2.27%) ▼|QCOM178.10-5.88 (-3.20%) ▼|RTX193.39-3.00 (-1.53%) ▼|SBUX106.17-1.17 (-1.09%) ▼|SCHW101.10-1.28 (-1.25%) ▼|SO95.96-0.51 (-0.53%) ▼|SPG221.28+1.79 (+0.82%) ▲|T21.30-0.26 (-1.18%) ▼|TMO534.62+6.11 (+1.16%) ▲|TMUS187.13-1.28 (-0.68%) ▼|TSLA396.18+1.42 (+0.36%) ▲|TXN305.55+6.98 (+2.34%) ▲|UBER72.08-2.18 (-2.94%) ▼|UNH425.19-3.90 (-0.91%) ▼|UNP288.30-0.83 (-0.29%) ▼|UPS113.67+0.78 (+0.69%) ▲|USB62.14-0.20 (-0.32%) ▼|V356.02-1.73 (-0.48%) ▼|VZ42.47-0.21 (-0.49%) ▼|WFC85.36-2.31 (-2.63%) ▼|WMT113.70-1.08 (-0.94%) ▼|XOM145.09+0.58 (+0.40%) ▲|
33.6 C
New York
Tuesday, July 14, 2026

Tag: 9018

newssourceFORcompanyinformationcontent1releasesmarket

Monaco Energy Boat Challenge expands with the launch of the World Series

MONACO, July 14, 2026 (GLOBE NEWSWIRE) -- After four intense days of action, the curtain falls on the 13th edition of the Monaco Energy Boat Challenge. Organized by the Yacht Club de Monaco, the event brought together 54 teams from 21 countries, ranging from France, Italy and Switzerland to countries as far away as India, Puerto Rico and China, alongside researchers, shipyards, companies and universities. 

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary disease

Basel, 21 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today topline results from the pivotal phase IIb ALIENTO (n=1,301) and the phase III ARNASA (n=1,375) trials investigating astegolimab compared to placebo, on top of standard of care maintenance therapy in people with moderate to very severe chronic obstructive pulmonary disease (COPD). The studies included a broad population: both former and current smokers, regardless of blood eosinophil count, who have a history of frequent exacerbations.

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

Basel, 15 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective immediately, for ELEVIDYS™ (delandistrogene moxeparvovec), for non-ambulatory Duchenne muscular dystrophy (DMD) patients, irrespective of age, in both clinical and commercial settings. In the commercial setting, non-ambulatory patients should no longer receive Elevidys. In the clinical trial setting, enrolment and dosing of non-ambulatory patients will be immediately paused until additional risk mitigation measures (e.g. immune modulatory treatment) are implemented in the study protocol. Health authorities, investigators and physicians are being informed so that patient care can be quickly adjusted.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags9018

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers